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ABSTRACT 
Many organisms, including plants, microbes and invertebrates produce compounds called 
as natural products.  The production of natural products often confers some advantage to the 
producing organism such as chemical defense from predators.  Other natural products can have a 
different role in the producing organism such as preventing or limiting ultraviolet light damage 
from the sun.  Such sun screens are found in microalgae and vascular plants.  These natural 
products have been shown to display cytotoxicity, anti-bacterial, anti-fungal, anti-viral, and anti-
parasitic activity. Due to the biological activity shown by many natural products, these molecules 
have been used in our pharmacopia. Compounds like penicillin, isolated from a fungus, and non-
pharmaceutical compounds such as ginseng from green tea are natural products used by humans 
to benefit human health.  As the investigation of natural products has resulted in a remarkable 
number of compounds of benefit to humankind, the continued study of secondary metabolism 
and natural products has and continues to be of great importance.  This thesis describes an 
investigation of the secondary metabolites of selected marine fungi to identify anti-microbial 
natural products as well as the UV protecting compounds of the endangered sea grass Halophila 
johnsonii.  Although no novel compounds could be characterized from the marine fungi, a 
collection of flavonoid derivatives was identified in Halophila johnsonii. 
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CHAPTER 1:  CHARACTERIZATION OF ULTRAVIOLET PROTECTING FLAVONOIDS 
FROM HALOPHILA JOHNSONII 
 
Introduction 
 Halophila johnsonii is a submerged marine angiosperm located only in the coastal 
areas of south-eastern Florida.  It has a very limited distribution within coastal lagoons and is 
found between Sebastian Inlet (27°51’N, 80°27’W) and Virginia Key (25°45’ N, 80°07”W) at 
depths from 3 meters and less (1).  It is the least abundant seagrass species within these areas (2).  
In 1998, due to its rare occurrence, H. johnsonii was listed as a threatened species on the Federal 
Register, the only marine angiosperm with that classification.  In contrast, it has been suggested 
that H. johnsonii is a new and invading species to the lagoons of south Florida and may not, in 
fact, be a threatened species (3).   In either case, H. johnsonii likely has an advantage for survival 
as it is the least abundant species within its area of population and has not been overgrown in the 
past eight years since its listing as a threatened species.  H. jonsonii’s advantage may be due to 
its establishment and survival in the shallow, more demanding waters of its environment (4).  
Previous work has shown that H. johnsonii has a higher ultraviolet (UV) light tolerance 
compared to Halophila decipiens, a genus member co-existing at deeper depths in south Florida 
lagoons (5).  Furthermore, acetone extracts of the leaves of both plants revealed a strong UV 
absorption at 345nm in H. johnsonii that was absent in H. decipiens (5).  Additional studies 
showed that H. johnsonii is capable of rapidly adjusting to high levels of UVB radiation through 
changes in the production of UV protective compounds and pigments (6).  It appears the 
production of these UV absorbing compounds gives H. johnsonii a competitive advantage over 
other species of seagrass, enabling it to survive the shallow, high UV areas of the intertidal zone.   
The production of UV protecting compounds in plants and microalgae is not unusual, and 
indeed the presence of natural sunscreens in various organisms has been known for decades.  The 
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sun emits three forms of UV radiation: UVA, UVB, and UVC.  UVC (200-280 nm) radiation is 
completely absorbed by the ozone layer.  However, UVA (320-400 nm) and UVB (280-320 nm) 
radiation penetrate the Earth’s atmosphere and can cause damaging effects to humans and other 
living organisms, including plants (7, 8).  For humans, sun damage from UV radiation manifests 
itself as burns and premature aging of the skin as well as increases the risk for skin cancer and 
cataracts.  The use of sunscreens before UV exposure from the sun has become necessary for 
people of all ages and ethnicities to protect against UV damage.   
In a parallel fashion to the application of sunscreens on human skin, a number of classes 
of secondary metabolites provide UV protection to a variety of organisms ranging from plants to 
marine invertebrates.  The largest class of naturally occurring UV protecting compounds is found 
in plants and is composed of a group of compounds known as the flavonoids.  Although there are 
more than five flavonoid structural types, the anthrocyanins and flavones represent the major 
compounds associated with UV protection due to their ability to absorb light in the 280-320nm 
(UVB) range (9).  This ability of flavonoids to absorb UVB light can prevent the DNA damage 
and photosystem damage induced by ultraviolet light (8).  Anthrocyanins can serve a dual 
purpose by providing not only UV protection to plants but also the pigments responsible for 
flower color.  Such UV protecting compounds of the flavonoid type occur mainly as O- or C- 
linked glycosides and are located in the outer tissue layers (10).  For instance, in the epidermal 
cells of the rice Oryza sativa, a series of  iso-orientin-O-glucosides were identified as UV 
protecting compounds (11).  In the frequently studied species Arabidopsis thaliana, kaempferol-
3-gentiobioside-7-rhamnoside, and kaempferol-3,7-dirhamnoside were found to protect the plant 
from UV damage (12).   
 3
Carotenoid pigments have also been linked to UV protection in plants.  In particular, it 
has been suggested that carotenoids play a role in photosynthetic protection from UVB damage 
in the Clark and Harosoy soybean (Glycine max) isolines (13).  More recently, a unique group of 
amino acid-based compounds known as the mycosporines (MAAs) have been identified as UV 
protecting compounds in a number of marine organisms.  MAAs absorb UV light in the 310-360 
nm range and have been found in terrestrial fungi, marine microalgae, as well as symbiotic 
invertebrates and vertebrates (14).  Interestingly it seems that MAAs are predominantly found in 
marine organisms and are not common in higher terrestrial plants that appear to rely on UV 
protection through flavonoid and carotenoid compounds.  Examples of structures from these 
different classes of UV protecting compounds are shown in Figure 1.   
 Based on the observation that the deeper water seagrass variant H. decipiens does not 
appear to contain any photoprotecting compounds, whereas the shallow-water variant H. 
johnsonii can adapt to alterations in UV exposure (5), we reasoned that it may utilize natural 
sunscreens as a means of UV protection.  Consequently, we embarked upon a chemical 
investigation of the secondary metabolites of H. johnsonii to determine if any metabolites may 
act as photoprotectants.   This investigation has revealed a series of flavonoid derivatives 
produced by H. johnsonii, that likely play a UV protecting role.   
Results and Discussion  
A purified fraction of the methanol extract of H. johnsonii yielded a complex mixture of 
UVB absorbing compounds.  Liquid chromatography-electrospray ionsization mass spectrometry 
(LC-ESIMS) analysis of the mixture resulted in the identification of five major compounds 
absorbing at 340 nm, and ranging in retention time between 19 and 25 minutes and a minor 
component eluting at 15.65 minutes (Figure 2a).   The total ion chromatograms for each peak  
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Figure 1.  The structures of UV absorbing compounds. 
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were generated with ESI operating in the negative ion mode (Figure 2b).  The ESI-MS spectra 
for peak 1 (R.T. 19.76 min) displayed ions at m/z 479 and 316.  Peak 2 (R.T. 21.076 min) had 
ions at m/z 463 and 301.  Peak 3 (R.T. 22.386 min) displayed ions at m/z 521, 316, and 284.  
Peak 4 (R.T. 23.70 min) showed ions at m/z 505, 301, and 284.  Finally, peak 5 (R.T. 25.00 min) 
showed ions at m/z 489 and 285.  The minor component had m/z ions at 957.5, 795.3, 633.4, and 
323.1.  The mass spectra of these six fractions obtained in negative ESI mode showed parent ion 
peaks as well as fragmentation peaks resulting from losses of 162 or 205 amu.  The loss of such 
fragment ions is entirely consistent with the presence of glycosyl and acylglycosyl moieties, 
respectively, in these UV absorbing compounds, a common feature in many natural products 
(15).   
Based on the observation that flavones are frequently glycosylated and absorb light in the 
UVB range, a flavone glycoside standard (leuteolin-7-glycoside) was purchased for comparison.  
The UV spectra of leuteolin-7-glycoside standard showed UV maximas at 215 nm, 250 nm, and 
350 nm (Figure 3a).  The UV spectra for each of the compounds of the H. johnsonii extract 
showed very similar maximas at 215, ~250, and 350 nm (Figure 3a).  Furthermore, the leuteolin-
7-glycoside standard eluted from the LC with similar retention time and displayed similar mass 
spectra and fragmentation ions as observed with the H. johnsonii compounds (Figure 3b).  The 
parent ion for the intact compound is represented by the [M-H]- ion at m/z 445.  Furthermore, in 
the electrospray ionization process, cleavage of the glycosyl bond results in a [M-162]- fragment 
ion at m/z 284 corresponding to the aglycone leuteolin.  These data supported the idea that the 
protectant compounds found in H. johnsonii were a mixture of flavone glycosides and 
acetylglycosides.   
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a. 
 
 
 
 
 
 
 
b. 
Figure 2. LC and MS chromatograms of H.johnsonii compounds 
a.  LC chromatogram of the H. johnsonii compounds with UV 
absorbance at 340 nm. 
b.  Mass spectra for the six UV active compounds in H. johnsonii. 
The compounds were analyzed in ESI- mode and represent [M-H]- 
ions.  
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Figure 3.  Luteolin-7-glycoside displays similar spectral properties to H. johnsonii 
 compounds . 
 a. The UV spectra of leuteolin-7-glycoside and H. johnsonii compound. 
 b. LC chromatogram (back) and ESIMS spectra (inset) for leutolin-7 
 glycoside standard.  
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Comparision of the 1H NMR spectra of the mixture and standard further supported the 
identification of the components as a series of glycosylated flavonoids.   The 1H NMR spectra of 
the mixture from H. johnsonii mixture displayed aromatic and hydroxyl resonances consistent 
with luteolin-7-glycoside.  As further support, the 1H NMR spectra also contained resonances 
around 5.0 ppm (Figure 4), consistent with a proton attached to an anomeric carbon of a sugar 
moiety such as glucose.  
Identification of individual flavone components was made based on the mass spectral 
data obtained for each compound, and by comparison with literature information.  The 5 major 
components of the H.johnsonii mixture retained the common flavone core and varied in the 
number on hydroxyl substituents attached to the core.  Each was also modified either a glycoside 
or acetyl glycoside moiety.  Using this analytical information, two flavone glycosides were 
identified. Peak 1 (19.73 min) was identified as a hexahydroxyflavone-glycoside (M.W. 480) as 
evidenced by the aglycone fragment peak at m/z 317.1 corresponding to the [M-162]- fragment 
ion and the parent [M-H]- ion at m/z 479.2.  Peak 2 (21.05) was characterized as a 
pentahyroxyflavone-glycoside (M.W. 464) as suggested by the parent [M-H]- peak at m/z 463.2 
and a fragment ion at m/z 301.1 corresponding to the aglycone and the loss of a sugar moiety.  
The final three components of the mixture contained the tetra-, penta-, and hexahydroxylated 
flavones modified with an acetylated glucose.  Peak 3 (22.41 min) represented the 
hexahydroxylated-acetylglycoside (M.W. 522) and was identified by the molecular ion [M-H]- at 
m/z 521.2.  The mass fragment ion at m/z 317.1 corresponds to the loss of the acetyl-glycoside of 
204 amu.  The pentahydroxyflavone acetylglycoside (M.W. 506), peak 4 (23.74 min), gave an 
[M-H]- ion peak at m/z 505.2 with a subsequent fragment ion at m/z 301.1 corresponding to the 
loss of the acetylglycoside moiety.  Finally, the most nonpolar constituent of the mixture, peak 5  
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Figure 4.  Comparision of 1H NMR spectra of luteolin-7-O-glycoside standards and H. johnsonii 
compounds. 
a. 1HNMR spectra of luteolin-7-O-glycoside 
b. 1HNMR spectra of H. johnsonii compounds 
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(25.05 min) was identified as a tetrahydroxylated-monoacetylglycoside (M.W. 490) by the [M-
H]- molecular ion at m/z 489.3.  A fragment ion at m/z 447.3 corresponding to the loss of an 
acetyl group as well as a [M-204]- fragment peak at m/z 285.1 corresponding to the loss of the 
acetylglycoside from the parent ion also supported the identification.  Through LC-MS analysis 
we identified two flavone glycosides and three flavone acetylglycosides in the Halophila 
johnsonii extract. 
One of the minor components of the mixtures with a retention time of 15.81 minutes 
(Figure 2a) displayed an interesting mass spectral fragmentation pattern (Figure 5).  Although we 
were unable to identify the flavone core of this molecule, we identified this constituent as a 
flavone tetraglycoside derivative.  The parent ion at [M-H]- m/z 957.6 sequentially lost two 
glycoside units yielding fragment ions at [M-162]- and [M-324]-m/z 795.5 and 633.2 
respectively.  Further fragmentation of 310 amu corresponding to the loss of another two sugars 
units resulted in an [M-H]- peak of the aglycone at m/z 323.2.   Table 1 summarizes the spectral 
data, type of flavone, and identification of the H. johnsonii compounds.   
LC-ESI MS was used to identify the UV absorbing constituents of H. johnsonii as a 
series of flavone glycosides.  The general structures of these compounds are shown in Figure 6.  
These compounds are widely distributed among plants, and their biosyntheses and functions are 
well-studied (10).  The extensive information and databases dealing with known flavonoid 
compounds assisted in the identification of these flavones by LC-MS methods, and these 
methods are now widely used as an analytical tool for this class of compound (15-17).  In fact, 
electrospray mass spectrometry, has become the most prominent method for flavonoid 
identification (18), particularly in combination with known standards when it can be used to 
identify flavonoid compounds.  However, NMR analysis is often still required for full structural  
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Figure 5.  The ESI- mass spectral fragmentation pattern and proposed structure of the flavone-
tetraglycoside 
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Table 1. The identification and spectral propteries of the H.johnsonii UV absorbing compounds. 
Peak tr (min) UV lmax (nm) [M-H]- (m/z) [M-H]- fractions (m/z) flavone
1 19.73 220,280,350 479 316 hexahydroxyflavone-O -glycoside
2 21.05 220,280,350 463 301 pentahydroxyflavone-O -glycoside
3 22.41 215,250sh,350 521 316 hexahydroxyflavone-O -acetylglycoside
4 23.74 220,280,350 505 301 pentahydroxyflavone-O -acetylglycoside
5 25.05 215,250sh,350 489 284 tetrahydroxyflavone-O -glycoside  
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Figure 6.  The general structures of the flavone glycosides in H. johnsonii 
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characterization and substitution pattern assignment.  Tandem mass spectrometry (MS/MS), can 
provide even more detailed fragmentation data, and hence valuable structural information of 
flavonoids, than can be obtained using a single mass spectrometer alone (18). Regardless of the 
techniques used, the identification of flavonoids by mass spectrometry is frequently reported in 
the literature.  Through the use of standards and MS, five flavone glycosides were identified 
from the extract of Halophila johnsonii.   
The flavone compounds identified in the Halophila johnsonii extract may possess many 
biological properties, but most likely serve as UV photoprotectants for the seagrass, which 
survives in highly light exposed shallow areas of Biscayne Bay. Thus these secondary 
metabolites are used to filter UV light and protect the plant from UVB damage to DNA.  It has 
been shown that the production of these compounds is upregulated with increased exposure to 
UV light (6).  Two of the flavone compounds occur as glycosides, and three are modified with an 
acetylated glucose moiety making all of the flavone constituents hydrophilic.  Such glycoside 
derivatives may be useful in the transportation of these compounds in the plant and may favor 
their location in the vacuoles of epidermal cells in the leaves (9).  A further study of various 
plant components such as the leaf, rhizome, stem, etc., might provide additional information as 
to the production and storage centers for these compounds.  
 The production of flavones by angiosperms is not unusual. In fact, flavones are abundant 
in the plant kingdom, but the largest flavone containing taxon is the angiosperms (10).  
Futhermore, the presence of flavone compounds within the Halophila genus has previously been 
observed.  Sulphated flavones have been noted in H. ballonis, H. engelmanni, H. stipulacea, and 
H. ovalis (19).  In addition to H. johnsonii, glycosylated flavones have been observed in smaller 
leaved members of Halophila (20).  Interestingly, and in support of their photoprotectant role, 
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the production of flavanoids appears to diminish in H. johnsonii when it is transplanted in deeper 
waters (5).  A further striking feature is the apparent absence of flavones in the related species H. 
decipiens that grows in adjacent deep water areas, and thus may not require such 
photoprotectants. However, it is also possible that H. decipiens may produce different 
photoprotectant compounds.  Regardless, a detailed investigation of the chemical constituents of 
H. decipiens seems warranted.   
This study identified six flavone glycosides in Halophila johnsonii that we believe help 
protect this shallow dwelling seagrass from UV damage.  This is the first characterization of 
secondary metabolites from this endangered species and sheds light on how this seagrass found 
its niche in the shallow waters of Biscayne Bay, FL.  Our findings are consistent with the 
presence of flavones among most of the Halophila sp., and the class and type of flavone may 
serve as a distinguishing characteristic between species and their geographic location. In addition 
to their biological functions, the distribution and type of flavones found among Halophila sp. 
May provide a useful chemotaxonomic tool in the classification of Halophila seagrasses. 
Experimental 
     Plant material 
 Plant material was collected by Jennifer Kunzelman and provided courtesy of Dr. 
Michael Durako. 
     Isolation and Purification 
The methanol extract from Halophilia johnsonii was initially fractionated by RP-C18 
(ENVI Sep-Pak) chromatography using a 20-100% H2O-MeOH gradient.  The Sep-Pak column 
was first flushed with 100% MeOH to activate the column packing and flush any column bleed 
through.  The column was then eluted with the methanol-water gradient.  The 20 % H2O-MeOH 
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fraction was then applied to a reversed-phase C18 column (Bakerbond 10 x 100 mm) and eluted 
with a methanol-water gradient.  Combination of fractions yielded two samples, 2.0 mg and 
0.5mg that absorbed light in the UVB range.  These compounds were further purified with high 
performance liquid chromatography (HPLC) using a reversed-phase C18 column  (Phenomenex 
Luna, 10 x 250 mm, 5μm) with a 5-80% H2O-MeOH gradient containing  0.02% acetic acid (0.5 
mL/min flow rate, 20 min) over 30 minutes.  Both compounds were subjected to LC-ESIMS 
analysis (Waters Micromass ZQ) equipped with a reversed-phase C18 column  (Phenomenex 
Luna, 2.5 x 150 mm, 5μm) and eluted with 5-80% H2O-MeOH gradient containing  0.02% acetic 
acid (0.2 mL/min, 20 min) over 30 minutes.   
     Spectroscopy 
 1H NMR and 13C NMR were recorded using a 500MHz Brüker instrument at room 
temperature. All spectra were recorded in CDCl3.  Chemical shifts are presented as ppm (δ) with 
respect to the chemical shift of the solvent used.  UV spectra were recorded with an Agilient 
1100 UV detector in line with the HPLC system.  ESI mass spectral data were obtained with a 
Waters Micromass ZQ linked to the Agilent HPLC instrument. 
CHAPTER 2: ISOLATION OF ANTIMICROBIAL SECONDARY METABOLITES FROM 
MARINE FUNGI 
Introduction 
 Infectious diseases were once considered curable illnesses, and if one antibiotic in the 
arsenal of drugs did not clear the infection, another would.  However, that is no longer the case.  
Microbes resistant to not one but multiple therapies are common and represent a global problem 
(21).  Ironically, hospitals are large reservoirs for breeding resistant bacterial strains.  In fact, 
approximately 50% of hospital-acquired infections are methicillin resistant Staphyloccocus 
aureus (MRSA) and most are also resistant to other antibiotics (22).  M. tuberculosis, responsible 
for TB infections, has numerous multi-drug resistant (MDR) strains for which six to seven drugs 
are needed for effective treatment (23).  With drug resistance on the rise and the number of 
reported MDR infections increasing, there is a great need for new antibiotic therapies.   
 Clinically used antibiotics are compounds that selectively target a bacterial protein that is 
unlike a human protein in either function or structure.  There are five main modes of action for 
antibacterial compounds: inhibition of cell wall biosynthesis, inhibition of protein synthesis, 
inhibition of RNA synthesis, inhibition of DNA synthesis, and inhibition of folic acid 
biosynthesis.  The penicillins, cephalosporins, and glycopeptides (e.g. vancomycin) all inhibit 
cell wall biosynthesis.  The beta-lactam antiobiotics (i.e. the penicillins and cephalosporins) 
inhibit of the cross-linking of the peptidoglycan layer of the bacterial cell wall.  These 
compounds are generally selective for gram positive bacteria because gram positive bacteria 
have a largeer peptidoglycan layer than gram negative bacteria that have a very small 
peptdioglycan membrane layer.  There are a number of antibacterial drug classes that inhibit the 
synthesis of bacterial proteins.  The bacterial ribosome that is responsible for protein synthesis is 
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distinctly different in structure compared to the human or eukaryotic ribosome.  Taking 
advantage of this, the aminoglycosides, macrolides, tetracyclines, and chloramphenical all bind 
to different portions of the bacterial ribosome halting protein synthesis.  Because these drug 
classes inhibit protein synthesis they are largely bactericidal (causing cell death) agents rather 
than bacteriostatic agents (slowing cell gowth) like the drugs that inhibit cell wall biosynthesis.  
The quinolone antiobiotics inhibit the synthesis of bacterial DNA through the inhibition of DNA 
gyrase, an enzyme only contained in bacteria that is responsible for relaxing DNA before 
replication can occur.  Finally, the trimethoprim and sulfonamide antibiotics inhibit bacterial 
synthesis of folic acid through inhibition of dihydrofolate reductase.  There are a limited number 
of known selective targets for anti-bacterial agents and the number of novel drug targets has been 
declining (24).  With antibiotic resistance posing one of the worlds most important public health 
issues, the discovery of novel antibacterial compounds is of utmost importance.  
Natural products have been the greatest source of successful antibiotic compounds 
throughout history.  The penicillins, cephalosporins, macrolides, tetracyclines are all antibacterial 
classes that were derived from natural product origins.  Over the years, 80 % of the bioactive, 
natural products isolated have been antibiotic compounds, and this trend is continuing (25, 26).  
Bacteria and fungi, in particular, have been a reliable source for the discovery of useful antibiotic 
compounds.  For example, the penicillins and cephalosporins are both clinically used drug 
classes derived from fungal natural product structures.  However, most of these leads have been 
derived from land-based or terrestrial organisms, and in recent times the discovery of totally new 
biologically active chemical compounds has diminished.  In this respect, the oceans, which cover 
over 70% of the planet and are home to an enormous biodiversity of species, offer vast 
opportunities in the discovery of new bioactive natural products (27).  Furthermore, there is 
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growing interest in exploring marine microbes such as fungi and bacteria as sources of new and 
unique secondary metabolites (28-30).  Marine fungi are predicted to be a valuable resource in 
the search and discovery of novel natural products.  It has been estimated that 90% of marine 
microorganisms, including fungi, have yet to be identified (31).  For microorganisms, survival in 
the marine environment is highly competitive and comes with a number of environmental 
stresses that can stimulate the production of secondary metabolites (32).  The isolation and 
chemical exploration of a number of marine fungal species have resulted in new structurally 
diverse natural products (32, 33), often displaying a variety of biological activities, such as anti-
bacterial, anti-viral, and anti-protozoal activities.   
Some examples of obligate marine fungal products are shown in Figure 7.  Cephalosporin 
C is the only marine fungal metabolite to have FDA approval as an antibiotic and falls into the 
beta-lactam class of drugs (34).   Melinacidine III, one of the first marine fungal metabolites 
reported, is an antimicrobial compound isolated from Corollospora puchella (33).  Pestalone, a 
novel antimicrobial benzophenone, has been discovered in extracts of the marine fungus 
Pestalotia sp. and has shown activity against vancomycin resistant enterococci and MRSA (35).  
In addition to these examples of antibiotic marine fungal metabolites, other compounds have 
been identified with additional biological activities. Sansalvamide A is a depsipeptide compound 
with activity against the DNA topoisomerase of Molluscam contagiosum virus (MCV), a virus 
implicated in the effects of HIV (36).  The macrolide aigialomycin D has been shown to be 
active against the malarial parasite Plasmodiun falciparum (37).  Communesin A is an alkaloid 
isolated from a Penicillin sp. found to be associated with a marine alga (38).  This compound and 
a derivative, communesin B, have shown activity against the P-388 human leukemia cell line.  
These are just a few examples of the novel, biologically active compounds discovered from  
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Figure 7. The structures of biologically active marine fungal natural products. 
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marine fungi that provide support for the investigation of marine fungi as sources of novel 
antibiotic compounds.   
Although marine fungi appear to be an excellent biological source for the discovery of 
natural products, there are a number of challenges associated with the successful laboratory 
culture of these organisms.  To begin with, not all fungi isolated in the field can be brought into 
culture in the laboratory.  Even when culture is possible, marine fungi can be naturally slow 
growing, and many factors of the culturing process can alter the growth rate of the organism.  
Culture temperature, pO2, pCO2, pH, and nutrient variations have all been shown to affect the 
rate of fungal growth in culture (39, 40).  Furthermore, even when laboratory cultures can be 
maintained, the production levels of secondary metabolites may be very low, necessitating large 
culture volumes in order to provide sufficient material for the complete structural 
characterization of a new compound.  Many of these factors have been cited as problems in the 
development of marine pharmaceuticals (41).   Even with the many challenges associated with 
the exploration of marine fungal natural products, these organisms still represent a source of 
natural product diversity with biological activity worth investigating.  We have examined a 
number of obligate marine fungi for the production of antimicrobial compounds and identified 
organisms producing interesting natural products. 
Results and Discussion 
 From organisms originally isolated and identified by the Kohlmeyers (42), a subset of 30 
obligate marine fungi, maintained in culture at the Center for Marine Science, formed the basis 
for this study.  Organic extracts of these fungi were screened for the presence of anti-microbial 
compounds using disc diffusion assays against two gram positive and two gram negative bacteria 
Bacillus subtilis, Staphalococcus epidermis, Pseudomonas aeruginosa, and E. coli, as well as for 
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the production of antifungal compounds using Candida albicans.  Five of the marine fungal 
strains were found to produce anti-bacterial compounds in culture, but none of the fungi yielded 
extracts that displayed growth inhibition of Candida albicans (Table 2).  Of those fungal extracts 
with detectable levels of anti-microbial activity, the extract of Camarosporium I show activity 
against gram-positive bacteria only.  This suggests that the antimicrobial compound produced by 
Camarosporium I is likely to target the cell-wall biosynthesis of gram-positive bacteria in a 
manner such as the penicillins and cephalosporins.  The extract from Humicola alpallonella 
showed biological activity against gram-negative bacteria only.  Small ribosomal and non-
ribosomal peptides have shown to be gram-negative selective agents, and the natural product 
produced by H. alpallonella could potentially act in that manner.  Three extracts from Sarcodella 
rhizophorae, Corollospora quinqueseptata, and Tiarosporella halymra showed anti-bacterial 
activity against both gram-positive and gram-negative bacteria. The natural products being 
produced by these organisms are likely to target bacterial protein synthesis or one of the enzymes 
involving the replication and transcription of DNA as both of these mechanisms effect gram 
positive and gram negative organisms equally.  These fungi could also be producing multiple 
anti-bacterial compounds with different bacterial targets. 
The five fungi displaying anti-bacterial activity were grown in 6 L batches with the aim 
of producing enough biomass to yield sufficient material to permit the isolation and purification 
of the active agents. Unfortunately, these fungi grew very slowly in liquid culture, and provided 
only small amounts of a crude organic extract. Consequently, cycles of growth and extraction 
were repeated many times in order to obtain sufficient amounts of material with which to 
progress forward with chemical purification and analysis (Appendix A).  This slowed progress 
and prevented the accumulation of sufficient material for chemical analysis. However, the  
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A n te n n o sp o ra  sa lin a n d n d n d
A q u a m a r in a  sp e c io sa n d n d n d
C a m a ro sp o r iu m  I x n d n d
C e r io sp o ro p s is  h a lim a n d n d n d
C o ro llo sp o ra  c a l i f o rn ic a n d n d n d
C o ro llo sp o ra  c a l i f o rn iu m  f i l i f o r n d n d n d
C o r l lo sp o ra  c a l i f o rn iu m  m a r i t im n d n d n d
C o ro llo sp o ra  c o lo s sa n d n d n d
C o ro llo sp o ra  n o v o fu sc a n d n d n d
C o ro llo sp o ra  p u lc h e l la n d n d n d
C o ro llo sp o ra  q u in q u e se p ta ta x x n d
G a e u m a n n o m y c e s  m e d u lla r is n d n d n d
H a lo sp h a e r io p s is  m e d io se tig e ra n d n d n d
H u m ic o la  a lo p a llo n e lla n d x n d
J u n c ig e n a  a d a rc a n d n d n d
L e p to sp h a e r ia  ty p h ic o la n d n d n d
L ig n ic o la  la e v is n d n d n d
L in e o la ta  rh izo p h o ra e n d n d n d
L u lw o r th ia  sp . n d n d n d
L u lw o r th ia  c f r .g ra n d isp o ra n d n d n d
M a ssa r in a  r ic i f e ra n d n d n d
M a ssa r io sp h a e r ia  e ru c a c e a n d n d n d
P a p u lo sp o ra  a m e ro sp o ra n d n d n d
P a ssa s in ie l la  o b io n e s n d n d n d
P e r ic o n ia  p ro l i f ic a n d n d n d
P e r ic o n ia  c f r .  P ro l i f ic a n d n d n d
P h a e o sp h a e r ia  h a l im a n d n d n d
P h o m a to sp o ra  b e lla m in u ta n d n d n d
S a rc o d o e l la  rh izo p h o ra e x x n d
S c ir rh ia  a n n u la ta n d n d n d
T ia ro sp o re l la  h a lm y ra x x n d
Table 2.  Antimicrobial activity of marine fungal culture extracts.  X indicates biological activity. 
nd indicates no activity detected. 
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ultimate reason for the lack of success was that the fungal cultures were withdrawn before 
completion of this project.   
 As the project progressed, and before the cultures became unavailable, the number of 
fungi in large-scale culture was reduced to two, Corollospora quinqueseptata and Tiarosporella 
halmyra.  This selection was based on the biological activity displayed by extracts of these 
organisms, and that this activity was reliably and consistently found.  By focusing on only two 
cultures, more culture volume could be devoted to only these two species.  By adopting this 
strategy, an increased amount of crude extract (~200mg) was obtained compared to prior cultures 
(~30mg) when all five were in larger scale culture.  Using bioassay-guided fractionation (Figure 
8) it was found that Corollospora quinqueseptata produced three anti-microbial compounds.  
The ESI mass spectral data (Figure 9) suggested the [M+H]+ or [M+Na]+ ions for these 
antimicrobial compounds were m/z 537, 625, and 713 respectively.  Interestingly, the spectra of 
each compound contained a fragment peak corresponding to a loss of 44 amu from the parent 
ion, suggesting the loss of a carboxylic acid moiety.  The UV spectra for the compounds also 
suggested the compounds contained interesting functionality, and displayed strong primary 
absorption at 220 nm and an additional absorption at 300 nm (Figure 9).  However, as previously 
mentioned, the fungal cultures became unavailable to us before sufficient material was obtained 
for further structural characterization.  
Tiarosporella halmyra was also cultured in four growth cycles from October 2002 to 
June 2003 and 72 L of culture material was generated for this fungi.  Biologically active 
compounds were found in the ethyl acetate extract from the broth only.  Although full structural 
characterization was not made, structural information for this compound was obtained by mass 
spectrometry and NMR.  The ultraviolet spectrum of the T. halmyra compound showed an UV  
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Figure 8.  Schematic representing bioassay-guided fractionation of natural products. 
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Figure 9.  UV (left) and mass spectral data (right) of the anti-bacterial compounds 
          isolated from Corollospora quinqueseptata. 
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maxima at 244 nm (Figure 10). This suggests the compound is composed of a simple conjugated 
diene system that would absorb around 215 nm and a few small modifications possibly an 
additional double bond or carbonyl that would extend that absorbance out to 244 nm.  The most 
abundant ion from the mass spectral data suggested an [M+H]+ at m/z 369 and an [M+Na]+ at 
m/z 391 (Figure10).  Two smaller peaks at m/z 337.2 and 305 are fragments ions with 
subsequent losses of 32 from the most abundant ion at m/z 369.  An additional peak atm/z  441.3 
was also present.  The mass spectral data suggested a molecular weight of 368 Da or 440 Da for 
the T. halmyra metabolite.  This datum suggested the compound cannot be an alkaloid because 
the molecular weight as determined by mass spectrometry appeared to be an even number.  All 
alkaloids contain a nitrogen atom within a heterocyclic ring and possess an odd numbered 
molecular weight.   
NMR data for the T. halymra compound was obtained and included 1H, 13C, DEPT135, 
HSQC and COSY.  13C spectroscopy requires a greater sample volume than proton NMR 
spectroscopy due the lower abundance of 13C in the environment.  In order to obtain 13C data, a 
small sample of <1 mg was used.  The 13C spectra suggested the sample was a mixture of two 
compounds, a major component with tall resonances containing ~12 carbons and a minor 
component containing ~ 30 resonances (Figure 11).  The 1H NMR spectrum for that sample (data 
not shown) also suggested the sample was composed of a major component and minor 
component.  The chemical shift data in the 13C spectrum suggested the mixture contained two 
natural products due to the interesting functionality of the compounds in the sample.  The13C 
spectrum contained resonances primarily in the aliphatic region from 10-30 ppm, but the 
spectrum also contained resonances indicative of carbons under oxygen or otherwise deshielded 
from an electronegative environment (40-80ppm), olefinic carbons between 100-150 ppm, and  
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Figure 10.  Spectral data for antimicrobial compound isolated from T.  halmyra. 
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Figure 11. NMR spectral data for antimicrobial compound isolated from 
Tiarosporella halmyra. 
a. 13C NMR (top) and DEPT135 (bottom) spectra 
b. 1H NMR spectra 
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two carbonyl carbons around 170-200 ppm.  DEPT 135 analysis of the sample revealed that the 
mixture contained approximately 13 quaternary centers (Figure 11).  Because the resonances for 
quaternary centers are low in peak intensity, it was not possible to determine which compound in 
the mixture was associated with those quaternary resonances, or indeed how many quaternary 
centers the major component possessed.   
1H NMR and 2D spectroscopy of a more purified sample provided more structural 
information for the bioactive T. halmyra compound. The 1H NMR spectrum displayed 
resonances in the aliphatic region (1-2 ppm), a deshielded resonance at 2.8 ppm, and olefinic 
resonances between 5-6 ppm (Figure 11).  There were no aromatic resonances in the spectrum 
(7-8 ppm) or aldehyde resonances near 10 ppm.  The 2D COSY (Figure 12) analysis for proton 
interactions of the sample revealed the olefinic doublet of doublets at 5.8 ppm interacts with a 
doublet 5.1 ppm.  This suggested these two proton signals share a common double bond in the 
molecule.  2D HSQC spectroscopy for carbon-proton interactions showed that 1H doublet at 5.1 
ppm is attached to a carbon that resonates at 113 ppm (Figure 13).  The carbon at 113 ppm was 
found to be a carbon bearing two hydrogen atoms from the DEPT 135 analysis (Figure 11).  This 
suggested that the olefin bond between the two protons at 5.1 and 5.8 ppm is a terminal alkene. 
The splitting pattern on the 1H spectrum for the doublet of doublets at 5.8 ppm had coupling 
constants with J= 7 Hz, and 12 Hz that are also consistent with a terminal alkene (43).   Further 
analysis of the COSY data revealed that another olefinic proton at 6.8 ppm is not coupled with 
another olefinic proton suggesting this olefinic bond must contain a quaternary carbon.  An 
olefinic bond containing a quaternary center is further supported by the presence of a quaternary 
carbon in the olefinic region of 100-150 ppm in the DEPT135 (Figure 11).  The HSQC spectrum 
also revealed that 1H signals at 5.15 and 5.3 ppm are not linked to any carbons in the molecule.   
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Figure 12. 2D COSY spectra for Tiarosporella halmyra compound 
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Figure 13. 2D HSQC spectrum for T. halmyra compound. 
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These singlet proton signals are hydroxyl proton signals in the molecule.  The 13C NMR and 
DEPT135 spectra revealed that there are two carbonyl carbons in the compound mixture that was 
analyzed.   The proton singlet at 2.8 ppm that integrates to one proton in a deshielded signal that 
is consistent with a proton signal near an oxygen in the molecule.  These data suggest that the T. 
halymra compounds contains at least one ketone moiety. The HSQC spectrum showed that the 
2.8 ppm proton is linked to a carbon resonance at 51.4 ppm.  DEPT135 analysis confirmed the 
50.1 ppm carbon to be a CH bearing carbon.  Together, the NMR data suggested that the T. 
halymra compound contains two olefinic bonds, a terminal bond as well as one involving a 
quaternary center, two hydroxyl substituents, a ketone carbonyl group, and a carbon bearing a 
single proton likely located next to the ketone moiety. 
More structural detail of the T. halymra metabolite was mined from the aliphatic region 
of the spectroscopic data.  The 1H NMR spectrum contains two singlet resonances at 1.1 ppm 
and 1.2 ppm that integrated to 3H and 7H respectively.  These resonances suggested the presence 
of three methyl group on the compound.  The HSQC and DEPT135 spectra confirmed that the 
1.1 ppm singlet was linked to a CH/CH3 carbon at 24.6 ppm.  The 7H singlet at 1.2 ppm was 
found to be linked to two CH/CH3 carbons at 22.5 and 32.8 ppm.  Because these three methyl 
groups were all singlets and not split by any other proton signals they all appeared to be attached 
to quaternary centers.  Furthermore, the deshielded aliphatic carbon resonance at 32.8 ppm 
linked to a non-deshielded resonance at 1.2 ppm is characteristic.  These resonances are 
consistent with reported values for gem-dimethyl groups attached to a quaternary center (43).  
The 1H NMR spectrum also showed a number of signals with CH2 splitting patterns between 1-2 
ppm.  Analyzing the HSQC spectrum, it revealed that in addition to the three methyl carbons on 
the major component of T. halymra, there were five additional carbons bearing hydrogens. All of 
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these carbons (18.1, 23.0, 26.9, 29.6, and 40.5 ppm) showed multiple 1H interaction suggesting 
these carbons had at least two attached protons.  The DEPT135 confirmed that these five carbon 
signals were CH2 signals for the T. halmyra compound.  The rigid and sharp shapes of the CH2 
peaks suggested that they were involved in a ring system.  All of the structural information for 
the T. halmyra metabolite suggested that the compound has a ring system and is composed of at 
least 14 carbons: 3 -CH3, 5 -CH2, -CH, -C=CH, -HC=CH2, and -C=O. 
The many structural details for the T. halmyra compound obtained suggested that the 
metabolite was likely to be a terpenoid.  This reasoning was based on the aliphatic nature of the 
compound, the non-aromatic ring system, the olefinic bonds, terminal methyl groups, as well as 
the carbonyl and hydroxyl moieties that are all common components of terpenoid compounds.   
Based on the number of identified carbons (14 carbons) in the major component it is likely that 
the compounds is a sesquiterpene composed of 15 carbons, the fourteen we identified and an 
additional quaternary center.  It is also probable that the minor component of the T. halymra 
mixed sample is either a sester- or tri-terpene composed of 25 or 30 carbons respectively.  
Terpenoid antibiotics are not unusual and have been reported in the literature. In fact, in 2006, 
Rojas et al reported the characterization of aegicerin, a triterpene antibiotic showing biologically 
activity against resistant strains of Mycobacterium tuberculosis (44).  Sesquiterpene antibiotics 
such as the series of lactones identified in C. spinosa are also found in the literature (45).  
Sesterterpene antibiotics have even been reported in marine fungi (32).  Although full structural 
characterization of the Tiarosporella halmyra metabolite was not accomplished, it is likely that 
the metabolite is terpenoid in origin and appears to contain interesting functionality.   
Experimental 
     Fungal material 
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 The fungal samples were collected by Jan and Brigitte Kohlmeyer from a variety of 
marine environments.  A subset of these fungal isolates were maintained in culture on agar plates 
at the mycology lab of the Center for Marine Science. Large-scale cultures, typically 6 L in 
volume, were grown in a liquid medium containing 38 ppt Instant Ocean, 0.5 g peptone, 1.0 g 
glucose, and 0.1 g yeast extract per liter of deionized water.   
     Fungal harvest and extraction 
Sterile 1.5 L culture flasks containing growth medium were inoculated with a portion of 
fungal culture taken from stock cultures.  The flasks were allowed to grow for a period of 
approximately eight weeks or until the top of the broth was covered with biomass.  Fungi were 
harvested by separation of broth and mycelia.  The spent culture broth was shaken against an 
equal volume of ethyl acetate (x 3) in a separatory funnel.  The combined organic extract was 
dried (MgSO4 anhydrous), filtered, and then concentrated in vacuo using a Buchi rotovap to 
yield the crude, organic broth extract.   
The combined mycelia were frozen with liquid nitrogen then crushed in a mortar and 
pestle.  The powdered cells were extracted with 80% aqueous methanol (100 mL/g cells), then 
filtered, and concentrated to dryness in vacuo.  The extraction procedure was repeated twice, and 
the combined cell extracts were dried and weighed.  
     Biological Assay 
 Bacterial assay plates, culture slants, and broth culture media were prepared with Nutrient 
Agar (Bacto) and Luria Broth (Bacto).  Candida albicans cultures and assay plates were 
prepared with potato dextrose agar (Bacto).  Cultures of E. coli and Pseudomonas aeruginosa 
(gram negative) as well as Staphylococcus epidermis, Bacillus subtilis (gram positive), and 
Candida albicans were cultured for use in antimicrobial assays.  Stock culture transfers were 
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performed regularly every two to four weeks.  The slant cultures were transferred to broth for use 
in the antimicrobial assays. 
Sterile assay plates were streaked with the test microorgamism.  A 20 μL aliquot of each 
1 mg/mL methanol-dissolved sample was placed on a disc (Schleicher and Schull Grade 740E- 
1/4in.).  Erythromycin (15μg), Rifampin (25μg), Vancomycin (30μg), and methanol (20μL) were 
used for positive and negative controls.  Plates were incubated at 37˚ C overnight and the results 
were taken the following day.  A positive result was indicated by a zone of growth inhibition 
(mm) around the sample disc.     
     Isolation 
 Generally, the fungal broth and mycelia organic extracts were first fractionated by 
reversed-phase C18 chromatography using either a SepPak or open column and elution with H2O-
MeOH gradient.  Each fraction was tested for biological activity using the suite of bioassays 
described above.  After analysis, bioactive fractions were pooled and further separated by either 
size-exclusion (Sephadex LH-20: MeOH elution) or reversed-phase C18 open column 
chromatography (Bakerbond: elution with H2O-MeOH mixtures).  The resulting fractions were 
further tested for biological activity, and if still impure were further purified by C18 reversed-
phase HPLC.  
     Spectroscopy 
 Mass spectral data were obtained on a Waters Micromass ZQ2000 instrument.  
Electrospray either in the positive and negative ionization mode was used with capillary 3.5V, 
variable cone voltage, extractor 5V, and RF lens 0.5V.  1H and 13C NMR data were obtained 
using a Brüker 500 MHz instrument. Spectra were recorded in CDCl3 or d4-methanol. 
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APPENDIX A 
 
Appendix A: Detailed description of bioassay-guided fractionations of marine fungi. 
Bioassay-guided fractionation of Camarosporium I  
 Approximately six liters of biomass of Camarosporium I (Fig. 1) was extracted (ethyl 
acetate) resulting in a crude, organic extract (32mg) and mycelia extract (190mg). The broth 
extract was applied to a reversed-phase C18 column (Bakerbond, 10 x 150 mm) and eluted with 
an aqueous methanol gradient (20, 30, 40, 50, 60, 70, 80, 100%) yielded twenty-seven fractions.  
The bioactive fractions were combined (2 mg).  The mycelia extract was applied to a reversed-
phase C18 (Bakerbond, 15 x 200 mm) column and eluted with a methanol-water gradient (20,30, 
40, 50, 60, 70, 80, 100% meOH) resulting in twenty-six fractions.  The bioactive fractions were 
combined (5mg) then added to the bioactive broth fractions.  The bioactive material (7 mg) was 
applied to a LH-20 column (Sephadex, 10 x 150 mm). Elution with two column volumes of 
methanol gave thirty-nine fractions. The bioactive fractions were combined (<1 mg) and lack of 
sufficient material prevented further separation or spectral analysis. 
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Figure 1.  Bioassay guided fractionation of Camarosporium I. 
 
Camarosporium I
broth mycelia
solvent extraction solvent extraction
(32mg) (150mg)
[-,-] [-,-]
RP C18 RP C18
AK2-44-1 AK2-44-2 AK2-44-3 AK2-43-1 AK2-43-2 AK2-43-3 AK2-43-4
[+,+] [-,-] [-,-] [+,+] [-,-] [-,-] [-,-]
(0mg) (0mg)
LH-20
AK2-50- 1-->13 AK2-50- 14-->17 AK2-50- 18-->25 AK2-50- 26-->39
[-,-] [+,+] [-,-] [-,-]
(0mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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Bioassay-guided fractionation of Corollospora quinqeseptata 
 In April 2002, 6 L of Corollospora quinqeseptata (Fig. 2) culture was harvested 
and a crude, organic broth extract (40 mg) and cellular extract (500 mg) was obtained.  The broth 
extract was applied to reversed-phase C18 (Analtech 10 x 150 mm) column chromatography and 
eluted with a methanol-water gradient (20, 30, 40, 50, 60, 70, 80, 100%).  The bioactive broth 
fractions (30 mg) were combined and applied to a reversed-phase C18 (Bakerbond, 10 x 100 mm) 
column. The column was eluted with 20, 30, 40, 50, 60, 70, 80, 100% methanol-water.  The 
bioactive material was combined (5.8 mg) and subjected to further purification by HPLC on a 
Zorbax RP-C18 column (250 mm x 10 mm). Separation was achieved by a 20 minute gradient 
from 55-95 % meOH-water (2 mL/min).  Four bioactive fractions were found: AK2-21-3 (0.3 
mg), AK2-21-4 (0.0 mg), AK2-21-5 (0.0 mg), and AK2-21-7 (0.6 mg).  The bioactive material 
was stored at -20˚ C.   
The mycelia extract (April 2002) (Fig. 3) was applied to a reversed-phase C18 column 
(Analtech, 15 x 200 mm) and eluted with a methanol-water gradient (20, 30, 40, 50, 60, 70, 80, 
100%).  The bioactive mycelia fractions (7 mg) were combined and applied to another reversed-
phase C18 (Bakerbond, 10 x 100 mm) column.  The column was eluted with 20, 30, 40, 50, 60, 
70, 80, 100% methanol-water. The bioactive fractions were combined (2.2 mg) and held for 
more biomass.  
 In October 2002 (Fig. 4), 6L of culture was harvested.  The organic extraction (ethyl 
acetate) of the 6 L of broth resulted in a crude, organic extract (52 mg).  The extract was applied 
to a reversed- phase C18 (Analtech, 10 x 150 mm) column and eluted  
 43
 
 
Figure 2.  Bioassay guided fractionation of Corollospora quinqueseptata broth in April 2002.   
Corollospora quinqueseptata
broth
Apr. 2002
solvent extraction
 [+,+]* 
(40mg)
RP C18 Analtech
AK1-88-1 -->2 AK1-88-3 -->4 AK1-88-5 -->6
 [+,+] [-,-] [-,-]
(30 mg)
RP C18 Bakerbond
AK1-93-2 -->26 AK1-93-27 -->38
[+,+] [-,-]
(16 mg)
HPLC
AK2-21-1 AK2-21-2 AK2-21-3 AK2-21-4 AK2-21-5 AK2-21-6
[-,-] [-,-] [+,+] [+,+] [+,+] [+,+]
(0.3 mg) (0.0 mg) (0.0 mg) (0.6 mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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Figure 3.  Bioassay guided fractionation of Corollospora quinqueseptata mycelia in April 2002.   
Corollospora quinqueseptata
mycelia
Apr. 2002
solvent extraction
[+,+]* 
(500mg)
RP C18 Analtech
AK1-88-1 -->2 AK1-88-3 -->4 AK1-88-5 -->6
 [+,+] [-,-] [-,-]
(7 mg)
RP C18 Bakerbond
AK1-91-1 -->25 AK1-91-25-54 AK1-91-55 -->58 AK1-91-59-->72
[-,-] [-,-] [+,+] [-,-]
(2.2 mg)
*[Indicates gram-positive assay result, gram-negative assay result]
 45
 
Figure 4.  Bioassay guided fractionation of Corollospora quinqueseptata broth in October 2002 
 
Corollospora quinqueseptata
Oct 2002 broth
solvent extraction
[+,+]* 
(52 mg)
RP C18 
AK2-45-1 -->3 AK2-45-4 -->20 AK2-45-21 -->23
 [-,-] [+,+] [-,-]
(29 mg)
LH-20
AK2-49-1 -->13 AK2-49-14 -->20 AK2-49-21 -->35
[-,-] [-,-] [+,+]
(23 mg)
RP C18 
AK2-55-4 AK2-55-5 AK2-55-6
[-,-] [-,-] [+,+]
(0.8 mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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with 20, 30, 40, 50, 60, 70, 80, 100% methanol-water.  The bioactive fractions eluted in the latter 
part of the column and were combined (29 mg) and applied to a LH-20 column  
 (Sephadex, 10 x 100 mm).  The column was eluted with two column volumes of methanol.  The 
bioactive fractions were combined (23 mg), applied to a reversed-phase C18 column (Bakerbond, 
10 x 100 mm), and eluted with 20, 30, 40, 50, 60, 70, 80, 100% methanol-water.  The bioactive 
fractions were combined as AK2-55-6 (0.8 mg) and used for LC-MS method development. 
 In December 2002, 16 L of Corollospora quinqeseptata (Fig. 5) was harvested. The 
organic extraction (ethyl acetate) of the 16 L of broth gave a crude, broth extract (430mg).  The 
organic broth extract was applied to a reversed-phase ENVI-C18 Sep-Pak cartridge (Supelco, 5g) 
and eluted with 20, 30, 40, 50, 60, 70, 80, 100% methanol-water. The bioactive broth fractions 
were combined (40 mg), applied to a LH-20 column (Sephadex, 10 x 100 mm), and eluted with 
two column volumes of methanol.  Based on differences in bioactivity, two bioactive fractions 
were formed (18 mg and 20mg).  The 20 mg fraction was applied to a reversed-phase C18 
(Bakerbond 10 x 75 mm) column and eluted with 20, 30, 40, 50, 60, 70, 80, 100% methanol-
water. The bioactive fractions were combined (1 mg). The two bioactive fractions (18 mg and 1 
mg) were subjected to further separation by HPLC on a Zorbax RP-C18 column (250mm x 
10mm). Separation was achieved by a 20 minute gradient from 55-95 % meOH-water 
(2mL/min).  Four bioactive fractions were found: AK2-66-2 (1 mg), AK2-76-4 (0.5 mg), AK2-
76-6 (0.5 mg), AK2-76-7 (0.5 mg) 
The mycelia (December 2002) (Fig. 6) was extracted (80% methanol-water) and gave a 
crude, organic extract (250mg).  The crude extract was applied to a reversed-phase  
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Figure 5.  Bioassay guided fractionation of Corollospora quinqueseptata broth in December 
2002. 
Corollospora quinqueseptata
broth
Dec-02
solvent extraction
[+,+]* 
(430 mg)
RP C18 Sep pak
AK2-64-1 -->5 AK2-64-6 -->10 
 [-,-] [+,+] 
(40mg)
LH-20
AK2-66-1 -->24 AK2-66-25 -->43 AK2-66-44 -->80
 [-,-] [+,+] [+,+]
(18mg) (20mg)
RP C18 Bakerbond
AK2-69-1 -->40 AK2-69-41 -->49 AK2-69-50 --> 53
 [-,-] [+,+]  [-,-]
(1mg)
      AK2-66- HPLC
1 2 3 4
[-,-] [+,+] [-,-] [-,-]
(1mg) 
AK2-76- HPLC
1 2 3 4 5 6 7
[-,-] [-,-] [-,-] [+,+] [-,-] [+,+] [+,+]
(0.5mg) (0.5mg)(0.5mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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Corollospora quinqueseptata
mycelia
Dec-02
solvent extraction
 [+,+]* 
(250 mg)
RP C18 Sep pak
AK2-65-1 -->5 AK2-65-6 -->8
 [-,-] [+,+]
(20 mg)
LH20
AK2-67-1 -->30 AK2-67-31-->35 AK2-67-36 -->51 AK2-67-51 -->79 AK2-67-80 -->82
 [-,-]  [-,-]  [+,+] [+,+]  [-,-]
(3 mg) (1 mg)
HPLC
AK2-73
1 2
[-,-] [-,-]
HPLC
AK2-74
1 2 3 4 5 6 7
[-,-] [-,-] [-,-] [+,+] [-,-] [+,+] [-,-]
(<1 mg) (<1 mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
 
Figure 6.  Bioassay guided fractionation of Corollospora quinqueseptata mycelia in December 
2002. 
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ENVI-C18 Sep-Pak cartridge (Supelco, 10g) and eluted with 20, 30, 40, 50, 60, 70, 80, 100% 
methanol-water.  The bioactive fractions were combined (20 mg), applied to a LH-20 column 
(Sephadex, 10 x 100 mm), and eluted with two column volumes of methanol.  Based on 
differences in bioactivity, two bioactive fractions were formed (1 mg and 3 mg).  The two 
bioactive fractions were subjected further separation by HPLC on a Zorbax RP-C18 column 
(250mm x 10mm). Separation was achieved by a 20 minute gradient from 55-95 % meOH-water 
(2mL/min).  Two bioactive fractions were formed:  AK2-74-4 (0 mg) and AK2-74-6 (0 mg).  All 
bioactive fractions were stored at -20˚C. 
 In April 2003, twenty-five liters of Corollospora quinqueseptata (Fig. 7) culture was 
harvested.  Organic extraction (ethyl acetate) of the broth gave a crude, organic extract (196 mg).  
The crude broth extract was applied to an ENVI-C18 Sep-Pak (Supelco, 5 g, 20 mL) column and 
was eluted with 20, 30, 40, 50, 60, 70, 80, 100 % methanol-water.  The bioactive fractions were 
combined (76 mg) and applied to a LH-20 (Sephadex, 10 x 150 mm) and eluted with two column 
volumes of methanol.  The bioactive fractions were combined (28 mg) and purified by HPLC on 
a Zorbax RP-C18 column (250mm x 10mm). Separation was achieved by a 20 minute gradient 
from 55-95 % meOH-water (2mL/min).  Four bioactive fractions were found: AK2-86-3 (1.5 
mg), AK2-86-5 (1.0 mg), AK2-86-6 (1.0 mg).  
 The harvested mycelia (April 2003) (Fig. 8) was extracted (80% methanol-water) and 
gave a crude, organic extract (210 mg).  The crude mycelia extract was applied to an ENVI-C18 
Sep-Pak column (Supelco, 5 g, 20 mL) and eluted with 20, 30, 40, 50, 60, 70, 80, 100 % 
methanol-water.  The bioactive fractions were combined (22 mg), applied to a LH-20 column 
(Sephadex, 10 x 100 mm), and eluted with two column volumes of 
 50
 
 
 
Figure 7.  Bioassay guided fractionation of Corollospora quinqueseptata broth in April 2003. 
Corollospora quinqueseptata
Broth April 2003
solvent extraction
[+,+]* 
(196 mg)
Sep-Pak RP-C18
AK2-82-1 -->2 AK2-82-3 -->4 AK2-82-5 -->9
 [-,-]  [-,-] [+,+]
(76 mg)
LH-20
AK2-84-1 -->15 AK2-84-15 -->57 AK2-84-58 -->80
[-,-] [+,+] [-,-]
(28 mg)
HPLC
AK2-86-1 AK2-86-2 AK2-86-3 AK2-86-4 AK2-86-5 AK2-86-6
[-,-] [-,-] [+,+] [-,-] [+,+] [+,+]
(1.5 mg) (1.0 mg) (1.0 mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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Corollospora quinqueseptata
mycelia
 April 2003
solvent extraction
[+,+]* 
(210 mg)
Sep-Pak RP-C18
AK2-87-1 -->3 AK2-87-4-->5 AK2-87-6 -->8
 [-,-]  [-,-] [+,+]
(22 mg)
LH-20
AK2-88-1 -->15 AK2-88-15 -->57 AK2-88-58 -->80
[-,-] [+,+] [-,-]
(7mg)
HPLC
AK2-90-1 AK2-90-2 AK2-90-3 AK2-90-4 AK2-90-5 AK2-90-6
[-,-] [-,-] [+,+] [-,-] [+,+] [+,+]
(0.5 mg) (0.5 mg) (0.3mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
 
Figure 8.  Bioassay guided fractionation of Corollospora quinqueseptata mycelia in April 2003. 
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methanol. The bioactive fractions were combined (7 mg) and subjected to HPLC on a Zorbax 
SB-C18 column (55-95 % methanol-water, 2 mL/min, 20 min).  Three bioactive fractions were 
identified: AK2-90-3 (0.5 mg), AK2-90-5 (0.5 mg), and AK2-90-6 (0.3 mg).   
 In June 2003, 25 L of Corollospora quinqueseptata (Fig. 9) culture was harvested.  
Organic extraction (ethyl acetate) of the broth gave a crude, organic extract (250 mg).  Organic 
extraction of the mycelia (80% methanol-water) gave a crude, organic extract (125 mg).   The 
crude broth and mycelia extracts were combined and applied to an ENVI-C18 Sep-Pak (Supelco, 
10 g, 60 mL) column and was eluted with 20, 30, 40, 50, 60, 70, 80, 100 % methanol-water.  The 
bioactive fractions were combined (70 mg), applied to a LH-20 (Sephadex, 10 x 150 mm), and 
eluted with two column volumes of methanol.  The bioactive fractions were combined (32 mg) 
and purified by HPLC on a Zorbax SB-C18 column (72 % methanol-water, 3.36 mL/min, 
isocratic).  Three bioactive fractions were identified AK2-99-4 (1.0mg), AK2-99-6 (1.0 mg), and 
AK2-99-7 (1.0mg) 
All of the bioactive material purified since April 2002 was combined based on TLC, 
bioassay, and HPLC retention times.  The fractions underwent final purification by HPLC on a 
Luna-C8 column (Phenomenex, 4.6 x 250 mm).  Separation was achieved with a 12 minute 
gradient of 40-60% methanol-water (1.5 mL/min). Three bioactive fractions were isolated:  
AK2-104-1 (0.7 mg), AK2-104-2 (0.5mg), and AK2-104-3 (0.5 mg).   
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Figure 9.  Bioassay guided fractionation of Corollospora quinqueseptata broth and mycelia in 
June 2003. 
Corollospora quinqueseptata
Broth and mycelia 
Jun-03
solvent extraction
[+,+]* 
(375 mg)
Sep-Pak RP-C18
AK2-97-1 -->3 AK2-97-4 -->8
 [-,-] [+,+]
(70 mg)
RP-C18 bakerbond
AK2-98-1 -->44 AK2-98-45 -->58 AK2-98-58 -->80
[-,-] [+,+] [-,-]
(32 mg)
HPLC
AK2-99-1 AK2-99-2 AK2-99-3 AK2-99-4 AK2-99-5 AK2-99-6 AK2-99-7
[-,-] [-,-] [-,-] [+,+] [-,-] [+,+] [+,+]
(1.0 mg) (1.0 mg) (1.0 mg)
*[Indicates gram-positive assay result, gram-negative assay result]
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Bioassay-guided fractionation of Saccardoella rhizophorae  
 Organic extraction (ethyl acetate) of 5 L of Saccardoella rhizophorae (Fig. 10) culture 
was obtained in October 2002 gave a crude, organic extract (28mg).  The extract was applied to a 
reversed-phase C18 (Analtech, 10 x 150 mm) column and eluted with 20, 30, 40, 50, 60, 70, 80, 
100% methanol-water. After TLC and bioassay, the bioactive fractions were combined (8.9 mg). 
The bioactive fraction was applied to a LH-20 (Sephadex, 10 x 75 mm) and eluted with two 
column volumes of methanol, which were characterized by TLC and bioassay.  The bioactive 
fractions were combined (0.3mg) and stored at -20°C. 
 
Bioassay-guided fractionation of Tiarosporella halmyra 
 In October 2002 (Fig. 11), 6.2 L of broth culture was harvested and extracted to yield a 
brown, oily crude extract (31.4 mg).  The cellular material was held in a -20ºC freezer until the 
next harvest.  The crude, organic, broth extract was subjected to a Reversed-phase C18 column 
(Bakerbond, 10 x 75 mm) and eluted with 20, 30, 40, 50, 60, 70, 80, 100 % methanol-water.  The 
bioactive fractions (14 mg) were combined and applied to a LH-20 column (Sephadex, 10 x 75 
mm). The column was eluted with two column volumes of methanol.  The resulting bioactive 
fractions were combined (6 mg) and purified by HPLC on a Zorbax SB-C18 column (10 x 250 
mm).  Separation was  
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Figure 10. Bioassay-guided fractionation of Saccardoella rhizophorae. 
  
 
 
   
 
 
 
 
 
Saccardoella rhizophorae
solvent extraction
[+,-]*
(28mg)
LH-20 
AK2-53-1--> 13 AK2-53-14-->23 AK2-53-24-40
[-,-] [+,-] [-,-]
(8.9mg)
bakerbond
AK2-60-1--> 35 AK2-60-35-->37 
[-,-] (0.3mg)
[+, -}
*[Indicates gram-positive result, gram-negative result]
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Tiarosporella halmyra
broth
Oct 2002 
solvent extraction
[+,+] 
(31.4mg)
RP C18 
AK2-42-2 -->9 AK2-42-10 -->16 AK2-42-17 -->31
 [+,+]  [-,-]  [-,-]
(14mg)
LH-20
AK2-48-1 -->14 AK2-48-15 -->22 AK2-48-23 -->27 AK2-48-28 -->33
 [-,-]  [+,+]  [-,-]  [-,-]
(6mg)
AK2-56 HPLC
1 2 3 4 5 6 7 8 9 10 11
[-,-] [-,-] [-,-] [-,-] [-,-] [-,-] [-,-] [-,-] [-,-] [-,-] [-,-]
[+,+]
(0.2 mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
 
 
Figure 11.  Bioassay guided fractionation of Tiarosporella halmyra broth in October 2002. 
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achieved by an isocratic method of 21 % acetonitrile-water for twenty minutes (2 mL/min).  
AK2-56-11 (0.2 mg) was found to be bioactive.   
 In December 2002 (Fig. 12), 16 L of broth and mycelia was harvested.  Organic 
extraction (ethyl acetate) of the broth gave an oily, brown crude extract (200 mg).   Organic 
extraction (80 % methanol-water) of the mycelia gave a crude organic extract (500 mg).  The 
mycelia extract showed no bioactivity.  The bioactive broth extract was applied to an ENVI-C18 
Sep-Pak cartridge (Supelco, 5 g, 20 mL) and eluted with 20, 30, 40, 50, 60, 70, 80, 100 % 
methanol-water. The bioactive fractions were combined (28mg), applied to a LH-20 column 
(Sephadex, 10 x 150mm), and eluted with two column volumes of methanol.  The resulting 
bioactive fractions were combined (17mg) and subjected to further separation by HPLC on a 
luna- C18 column (Phenomenex, 10 x 250 mm). Separation was achieved with 51% acetonitrile-
water (20 min, isocratic 3mL/min) followed by 95 % acetonitrile –water (isocratic, 20 min, 
3mL/min).  A single bioactive fraction was found: AK2-79-6 (0.5 mg) 
 In April 2003 (Fig. 13), 25 L of culture was harvested.  Organic extraction (ethyl acetate) 
of the broth gave an oily, brown crude extract (280 mg).   Organic extraction (80 % methanol-
water) gave a crude organic extract (550 mg).  Again, the mycelia extract showed no bioactivity 
and was stored at -20°C.  The bioactive broth extract was applied to an ENVI-C18 Sep-Pak 
cartridge (Supelco, 5 g, 20 mL) and was eluted with 20, 30, 40, 50, 60, 70, 80, 100 % methanol-
water. The bioactive fractions were combined (76 mg), applied to a LH-20 column (Sephadex, 
10 x 150 mm), and eluted with two column volumes of methanol.  The resulting bioactive 
fractions were combined (28 mg) and subjected to further separation by HPLC on a luna- C18 
column (Phenomenex, 10 x 250  
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Tiarosporella halmyra
broth
Dec-03
solvent extraction
 [+,+]* 
(200mg)
RP C18 Sep pak
AK2-59-1 -->3 AK2-59-4-->8 
[-,-] [+,+]
(28 mg)
LH-20
AK2-75-1-->14 AK2-75-15-->32 Ak2-75-33-->41 AK2-75-42 -->48
[-,-]  [+,+] [-,-] [-,-]
(17 mg)
HPLC
AK2-79-1 AK2-79-2 AK2-79-3 AK2-79-4 AK2-79-5 AK2-79-6
[-,-] [-,-] [-,-] [-,-] [-,-]  [+,+]
(0.5 mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
Figure 12.  Bioassay guided fractionation of Tiarosporella halmyra broth in December 2002. 
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Tiarosporella halmyra
broth
Apr-03
solvent extraction
 [+,+]* 
(280mg)
RP C18 Sep pak
AK2-81-1 -->6 AK2-81-6-->8 
[-,-] [+,+]
(76 mg)
LH-20
AK2-83-1-->24 AK2-83-24-->37 Ak2-83-40-->70 AK2-75-42 -->48
[-,-]  [+,+] [-,-] [-,-]
(28 mg)
HPLC
AK2-79-
AK2-89-1 AK2-89-2 AK2-89-3 AK2-89-4 AK2-89-5
[-,-] [-,-] [-,-] [+,+] [-,-]
(1.0 mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
Figure 13.  Bioassay guided fractionation of Tiarosporella halmyra broth in April 2003. 
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mm). Separation was achieved with 51% acetonitrile-water (20 min, isocratic 3mL/min) 
followed by 95 % acetonitrile –water (isocratic, 20 min, 3mL/min).  A single bioactive fraction 
was found: AK2-89-4 (1.0 mg) 
 In June 2003 (Fig. 14), 25 L of culture was harvested.  Organic extraction (ethyl acetate) 
of the broth gave an oily, brown crude extract (179 mg).   Organic extraction (80 % methanol-
water) gave a crude organic extract (350 mg).  The mycelia extract showed no bioactivity.  The 
bioactive broth extract was applied to an ENVI-C18 Sep-Pak cartridge (Supelco, 5 g, 20 mL) and 
was eluted with 20, 30, 40, 50, 60, 70, 80, 100 % methanol-water. The bioactive fractions were 
combined (41 mg), applied to a LH-20 column (Sephadex, 10 x 150mm), and eluted with two 
column volumes of methanol.  The resulting bioactive fractions were combined (18 mg) and 
subjected to further separation by HPLC on a luna- C18 column (Phenomenex, 10 x 250 mm). 
Separation was achieved with 51% acetonitrile-water (20 min, isocratic 3mL/min) followed by 
95 % acetonitrile –water (isocratic, 20 min, 3mL/min).  A single bioactive fraction was found: 
AK2-96-3 (1.0 mg). 
 The bioactive material from Tiarosporella halmyra was combined and applied to a Si-gel 
column (EM Science, 10 x 100 mm).  The column was eluted with two volumes of 9:1 
Chloroform:Methanol.  The bioactive fractions were combined as AK2-101-1 (1.5 mg). 
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Tiarosporella halmyra
broth
Jun-03
solvent extraction
 [+,+]* 
(179mg)
RP C18 Sep pak
AK2-93-1 -->6 AK2-93-6-->8 
[-,-] [+,+]
(41 mg)
LH-20
AK2-95-1-->24 AK2-95-24-->32 Ak2-95-32-->50 AK2-95-51 -->70
[-,-]  [+,+] [-,-] [-,-]
(18 mg)
AK2-79- HPLC
AK2-96-1 AK2-96-2 AK2-96-3 AK2-96-4 AK2-96-5
[-,-] [-,-] [-,-] [+,+] [-,-]
(1.0 mg)
*[Indicates gram-positive assay result, gram-negative assay result]  
 
Figure 14.  Bioassay guided fractionation of Tiarosporella halmyra broth in April 2003. 
 
 
